As the patient phenotype was compatible with a mitochondrial disease, we performed a fractionation analysis to determine the subcellular localization of HACE1 in control fibroblasts and evaluate whether HACE1 could be associated to mitochondria. This evidence concerns the gene HACE1 and inborn mitochondrial metabolism disorder.